1
|
Johnson CN, Ha AS, Chen E and Davidson D:
Lipomatous soft-tissue tumors. J Am Acad Orthop Surg. 26:779–788.
2018. View Article : Google Scholar : PubMed/NCBI
|
2
|
Waters R, Horvai A, Greipp P, John I,
Demicco EG, Dickson BC, Tanas MR, Larsen BT, Ud Din N, Creytens DH,
et al: Atypical lipomatous tumour/well-differentiated liposarcoma
and de-differentiated liposarcoma in patients aged ≤40 years: A
study of 116 patients. Histopathology. 75:833–842. 2019. View Article : Google Scholar : PubMed/NCBI
|
3
|
Thway K: Well-differentiated liposarcoma
and dedifferentiated liposarcoma: An updated review. Semin Diagn
Pathol. 36:112–121. 2019. View Article : Google Scholar : PubMed/NCBI
|
4
|
Xu C, Ma Z, Zhang H, Yu J and Chen S:
Giant retroperitoneal liposarcoma with a maximum diameter of 37 cm:
A case report and review of literature. Ann Transl Med. 8:12482020.
View Article : Google Scholar : PubMed/NCBI
|
5
|
Wang L, Luo R, Xiong Z, Xu J and Fang D:
Pleomorphic liposarcoma: An analysis of 6 case reports and
literature review. Medicine (Baltimore). 97:e99862018. View Article : Google Scholar : PubMed/NCBI
|
6
|
Enzinger FM and Winslow DJ: Liposarcoma. A
study of 103 cases. Virchows Arch Pathol Anat Physiol Klin Med.
335:367–388. 1962. View Article : Google Scholar : PubMed/NCBI
|
7
|
Mankin HJ, Mankin KP and Harmon DC:
Liposarcoma: A soft tissue tumor with many presentations.
Musculoskelet Surg. 98:171–177. 2014. View Article : Google Scholar : PubMed/NCBI
|
8
|
Creytens D: What's new in adipocytic
neoplasia? Virchows Arch. 476:29–39. 2020. View Article : Google Scholar : PubMed/NCBI
|
9
|
Mashima E, Sawada Y and Nakamura M: Recent
advancement in atypical lipomatous tumor research. Int J Mol Sci.
22:9942021. View Article : Google Scholar : PubMed/NCBI
|
10
|
Creytens D, Mentzel T, Ferdinande L, van
Gorp J, Van Dorpe J and Flucke U: Atypical mitoses are present in
otherwise classical pleomorphic lipomas-reply. Hum Pathol.
81:300–302. 2018. View Article : Google Scholar : PubMed/NCBI
|
11
|
Fletcher CD: The evolving classification
of soft tissue tumours-an update based on the new 2013 WHO
classification. Histopathology. 64:2–11. 2014. View Article : Google Scholar : PubMed/NCBI
|
12
|
Kallen ME and Hornick JL: The 2020 WHO
Classification: What's New in Soft tissue tumor pathology? Am J
Surg Pathol. 45:e1–e23. 2021. View Article : Google Scholar : PubMed/NCBI
|
13
|
Choi KY, Jost E, Mack L and
Bouchard-Fortier A: Surgical management of truncal and extremities
atypical lipomatous tumors/well-differentiated liposarcoma: A
systematic review of the literature. Am J Surg. 219:823–827. 2020.
View Article : Google Scholar : PubMed/NCBI
|
14
|
Vijay A and Ram L: Retroperitoneal
liposarcoma: A comprehensive review. Am J Clin Oncol. 38:213–219.
2015. View Article : Google Scholar : PubMed/NCBI
|
15
|
Gyllborg D, Langseth CM, Qian X, Choi E,
Salas SM, Hilscher MM, Lein ES and Nilsson M: Hybridization-based
in situ sequencing (HybISS) for spatially resolved transcriptomics
in human and mouse brain tissue. Nucleic Acids Res. 48:e1122020.
View Article : Google Scholar : PubMed/NCBI
|
16
|
Ortega MA, Saez MA, Fraile-Martínez O,
Asúnsolo Á, Pekarek L, Bravo C, Coca S, Sainz F, Mon MÁ, Buján J
and García-Honduvilla N: Increased angiogenesis and
lymphangiogenesis in the placental villi of women with chronic
venous disease during pregnancy. Int J Mol Sci. 21:24872020.
View Article : Google Scholar : PubMed/NCBI
|
17
|
Guadagno E, Peltrini R, Stasio L,
Fiorentino F, Bucci L, Terracciano L and Insabato L: A challenging
diagnosis of mesenchymal neoplasm of the colon: Colonic
dedifferentiated liposarcoma with lymph node metastases-a case
report and review of the literature. Int J Colorectal Dis.
34:1809–1814. 2019. View Article : Google Scholar : PubMed/NCBI
|
18
|
Bagaria SP, Gabriel E and Mann GN:
Multiply recurrent retroperitoneal liposarcoma. J Surg Oncol.
117:62–68. 2018. View Article : Google Scholar : PubMed/NCBI
|
19
|
Binh MB, Sastre-Garau X, Guillou L, de
Pinieux G, Terrier P, Lagace R, Aurias A, Hostein I and Coindre JM:
MDM2 and CDK4 immunostainings are useful adjuncts in diagnosing
well-differentiated and dedifferentiated liposarcoma subtypes: A
comparative analysis of 559 soft tissue neoplasms with genetic
data. Am J Surg Pathol. 29:1340–1347. 2005. View Article : Google Scholar : PubMed/NCBI
|
20
|
McCormick Y, Cols D, Mentzel T, Beham A
and Fletcher CD: Dedifferentiated liposarcoma. Clinicopathologic
analysis of 32 cases suggesting a better prognostic subgroup among
pleomorphic sarcomas. Am J Surg Pathol. 18:1213–1223. 1994.
View Article : Google Scholar : PubMed/NCBI
|
21
|
Kim T, Murakami T, Oi H, Tsuda K,
Matsushita M, Tomoda K, Fukuda H and Nakamura H: CT and MR imaging
of abdominal liposarcoma. AJR Am J Roentgenol. 166:829–833. 1996.
View Article : Google Scholar : PubMed/NCBI
|
22
|
Munk PL, Lee MJ, Janzen DL, Connell DG,
Logan PM, Poon PY and Bainbridge TC: Lipoma and liposarcoma:
Evaluation using CT and MR imaging. AJR Am J Roentgenol.
169:589–594. 1997. View Article : Google Scholar : PubMed/NCBI
|
23
|
Keung EZ, Hornick JL, Bertagnolli MM,
Baldini EH and Raut CP: Predictors of outcomes in patients with
primary retroperitoneal dedifferentiated liposarcoma undergoing
surgery. J Am Coll Surg. 218:206–217. 2014. View Article : Google Scholar : PubMed/NCBI
|
24
|
Jakob J, Tunn PU, Hayes AJ, Pilz LR, Nowak
K and Hohenberger P: Oncological outcome of primary non-metastatic
soft tissue sarcoma treated by neoadjuvant isolated limb perfusion
and tumor resection. J Surg Oncol. 109:786–790. 2014. View Article : Google Scholar : PubMed/NCBI
|
25
|
Artigas Raventós V: Mesenchymal
tumors-sarcoma: A new AEC work group. Cir Esp (Engl Ed).
96:527–528. 2018.(In English, Spanish). View Article : Google Scholar : PubMed/NCBI
|
26
|
Baratti D, Pennacchioli E, Kusamura S,
Fiore M, Balestra MR, Colombo C, Mingrone E, Gronchi A and Deraco
M: Peritoneal sarcomatosis: Is there a subset of patients who may
benefit from cytoreductive surgery and hyperthermic intraperitoneal
chemotherapy? Ann Surg Oncol. 17:3220–3228. 2010. View Article : Google Scholar : PubMed/NCBI
|
27
|
Baumgartner JM, Ahrendt SA, Pingpank JF,
Holtzman MP, Ramalingam L, Jones HL, Zureikat AH, Zeh HJ III,
Bartlett DL and Choudry HA: Aggressive locoregional management of
recurrent peritoneal sarcomatosis. J Surg Oncol. 107:329–334. 2013.
View Article : Google Scholar : PubMed/NCBI
|
28
|
Bonvalot S, Cavalcanti A, Le Pechoux C,
Terrier P, Vanel D, Blay JY, Le Cesne A and Elias D: Randomized
trial of cytoreduction followed by intraperitoneal chemotherapy
versus cytoreduction alone in patients with peritoneal
sarcomatosis. Eur J Surg Oncol. 31:917–923. 2005. View Article : Google Scholar : PubMed/NCBI
|
29
|
Lim SJ, Cormier JN, Feig BW, Mansfield PF,
Benjamin RS, Griffin JR, Chase JL, Pisters PW, Pollock RE and Hunt
KK: Toxicity and outcomes associated with surgical cytoreduction
and hyperthermic intraperitoneal chemotherapy (HIPEC) for patients
with sarcomatosis. Ann Surg Oncol. 14:2309–2318. 2007. View Article : Google Scholar : PubMed/NCBI
|